NovaBridge Biosciences (NBP) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.26, -2.33% vs the prior close of $1.29.
- Volume 350.69K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NBP dips 2.3% to $1.26, a 52-week low. Closed at $1.26, -2.33% vs the prior close of $1.29. Day range $1.26–$1.31, opened at $1.30.
NBP daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — NBP dips 2.3% to $1.26, a 52-week low
- Closed at $1.26, -2.33% vs the prior close of $1.29. Day range $1.26–$1.31, opened at $1.30.
- Volume was 350.69K shares, 0.8x its 50-day average of 427.67K.
- Price is -22.8% vs its 50-day average ($1.63) and -45.6% vs its 200-day average ($2.32).
- 52-week range $1.26–$6.79; today's close sits at 0% of that range, 81.4% below the 52-week high.
Oct 15, 2026 — NBP rises 0.8% to $1.29
- Closed at $1.29, +0.78% vs the prior close of $1.28. Day range $1.29–$1.32, opened at $1.29.
- Volume was 388.90K shares, 0.9x its 50-day average of 422.95K.
- Price is -21.4% vs its 50-day average ($1.64) and -44.6% vs its 200-day average ($2.33).
- 52-week range $1.26–$6.79; today's close sits at 1% of that range, 81.0% below the 52-week high.
Oct 14, 2026 — NBP dips 0.8% to $1.28, a 52-week low, 3 down days in a row
- Closed at $1.28, -0.78% vs the prior close of $1.29. Day range $1.26–$1.30, opened at $1.28.
- Volume was 426.90K shares, 1.0x its 50-day average of 419.41K.
- Price is -22.3% vs its 50-day average ($1.65) and -45.4% vs its 200-day average ($2.34).
- 52-week range $1.26–$6.79; today's close sits at 0% of that range, 81.1% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — NBP dips 2.3% to $1.29, a 52-week low
- Closed at $1.29, -2.27% vs the prior close of $1.32. Day range $1.26–$1.34, opened at $1.33.
- Volume was 711.50K shares, 1.7x its 50-day average of 408.55K.
- Price is -22.1% vs its 50-day average ($1.66) and -45.3% vs its 200-day average ($2.36).
- 52-week range $1.26–$6.79; today's close sits at 1% of that range, 81.0% below the 52-week high.
- SEC filings that day: 6-K.
Oct 12, 2026 — NBP slides 5.4% to $1.32, a 52-week low
- Closed at $1.32, -5.38% vs the prior close of $1.39. Day range $1.31–$1.40, opened at $1.40.
- Volume was 273.90K shares, 0.7x its 50-day average of 406.46K.
- Price is -20.6% vs its 50-day average ($1.66) and -44.4% vs its 200-day average ($2.37).
- 52-week range $1.31–$6.79; today's close sits at 0% of that range, 80.6% below the 52-week high.
Oct 9, 2026 — NBP rises 1.8% to $1.39
- Closed at $1.39, +1.82% vs the prior close of $1.37. Day range $1.37–$1.42, opened at $1.38.
- Volume was 295.60K shares, 0.7x its 50-day average of 405.61K.
- Price is -16.3% vs its 50-day average ($1.67) and -41.6% vs its 200-day average ($2.39).
- 52-week range $1.31–$6.79; today's close sits at 2% of that range, 79.5% below the 52-week high.
Oct 8, 2026 — NBP ends flat (+0.0%) to $1.37
- Closed at $1.37, +0.00% vs the prior close of $1.37. Day range $1.34–$1.38, opened at $1.37.
- Volume was 250.10K shares, 0.6x its 50-day average of 406.54K.
- Price is -18.1% vs its 50-day average ($1.67) and -43.0% vs its 200-day average ($2.41).
- 52-week range $1.31–$6.79; today's close sits at 1% of that range, 79.8% below the 52-week high.
Oct 7, 2026 — NBP dips 2.1% to $1.37
- Closed at $1.37, -2.14% vs the prior close of $1.40. Day range $1.37–$1.41, opened at $1.40.
- Volume was 353.90K shares, 0.9x its 50-day average of 404.41K.
- Price is -18.3% vs its 50-day average ($1.68) and -43.4% vs its 200-day average ($2.42).
- 52-week range $1.31–$6.79; today's close sits at 1% of that range, 79.8% below the 52-week high.
Oct 6, 2026 — NBP rises 2.9% to $1.40, 3 up days in a row
- Closed at $1.40, +2.94% vs the prior close of $1.36. Day range $1.38–$1.44, opened at $1.38.
- Volume was 379.80K shares, 0.9x its 50-day average of 400.32K.
- Price is -16.9% vs its 50-day average ($1.68) and -42.4% vs its 200-day average ($2.43).
- 52-week range $1.31–$6.79; today's close sits at 2% of that range, 79.4% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — NBP rises 0.4% to $1.36
- Closed at $1.36, +0.37% vs the prior close of $1.36. Day range $1.35–$1.38, opened at $1.37.
- Volume was 185.00K shares, 0.5x its 50-day average of 400.60K — lighter than usual.
- Price is -19.6% vs its 50-day average ($1.69) and -44.4% vs its 200-day average ($2.45).
- 52-week range $1.31–$6.79; today's close sits at 1% of that range, 80.0% below the 52-week high.
Oct 2, 2026 — NBP rises 1.1% to $1.36
- Closed at $1.36, +1.12% vs the prior close of $1.34. Day range $1.33–$1.36, opened at $1.34.
- Volume was 252.90K shares, 0.6x its 50-day average of 403.84K.
- Price is -20.3% vs its 50-day average ($1.70) and -44.9% vs its 200-day average ($2.46).
- 52-week range $1.31–$6.79; today's close sits at 1% of that range, 80.0% below the 52-week high.
NBP latest news & SEC filings
Every SEC filing by or about NBP in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Dennis Phillip Andrew converted options/RSUs into 23,695 shares on Sep 17, 2026; now holds 181,636
- Dennis Phillip Andrew sold 8,209 shares at $0.71 (≈$5.83K) on Sep 18, 2026; now holds 173,427
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 18, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Cao Sean Wuxiong sold 107,978 shares at $0.74 (≈$79.90K) on Sep 9, 2026
- Cao Sean Wuxiong sold 107,978 shares at $0.74 (≈$79.90K) on Sep 9, 2026
- Cao Sean Wuxiong sold 107,978 shares at $0.74 (≈$79.90K) on Sep 9, 2026
- Cao Sean Wuxiong sold 107,978 shares at $0.74 (≈$79.90K) on Sep 9, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 9, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 20, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 20, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 17, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jul 24, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 17, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 29, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade NBP
- How much it moves: over the last 20 sessions the average daily move was 2.00% (largest 5.4%).
- Liquidity: about 693.68K shares (≈$874.04K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.26 vs a range of $1.26–$6.79 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Phillip Andrew Dennis sold 8,209 shares on Sep 18, 2026.
- Latest filings: 6-K Oct 13, 2026; 6-K Sep 8, 2026; 6-K Sep 8, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
NBP market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.30 | 1.31 | 1.26 | 1.26 | 350.69K |
| Oct 15, 2026 | 1.29 | 1.32 | 1.29 | 1.29 | 388.90K |
| Oct 14, 2026 | 1.28 | 1.30 | 1.26 | 1.28 | 426.90K |
| Oct 13, 2026 | 1.33 | 1.34 | 1.26 | 1.29 | 711.50K |
| Oct 12, 2026 | 1.40 | 1.40 | 1.31 | 1.32 | 273.90K |
| Oct 9, 2026 | 1.38 | 1.42 | 1.37 | 1.39 | 295.60K |
| Oct 8, 2026 | 1.37 | 1.38 | 1.34 | 1.37 | 250.10K |
| Oct 7, 2026 | 1.40 | 1.41 | 1.37 | 1.37 | 353.90K |
| Oct 6, 2026 | 1.38 | 1.44 | 1.38 | 1.40 | 379.80K |
| Oct 5, 2026 | 1.37 | 1.38 | 1.35 | 1.36 | 185.00K |
| Oct 2, 2026 | 1.34 | 1.36 | 1.33 | 1.36 | 252.90K |
| Oct 1, 2026 | 1.36 | 1.39 | 1.31 | 1.34 | 342.00K |
| Sep 30, 2026 | 1.38 | 1.40 | 1.35 | 1.37 | 250.30K |
| Sep 29, 2026 | 1.38 | 1.41 | 1.35 | 1.37 | 294.60K |
| Sep 28, 2026 | 1.38 | 1.39 | 1.35 | 1.36 | 374.90K |
| Sep 25, 2026 | 1.43 | 1.44 | 1.32 | 1.38 | 6.61M |
| Sep 24, 2026 | 1.52 | 1.54 | 1.42 | 1.45 | 831.50K |
| Sep 23, 2026 | 1.58 | 1.59 | 1.50 | 1.53 | 592.90K |
| Sep 22, 2026 | 1.61 | 1.62 | 1.54 | 1.59 | 464.80K |
| Sep 21, 2026 | 1.63 | 1.64 | 1.61 | 1.61 | 243.60K |
About NovaBridge Biosciences
NovaBridge Biosciences (NBP) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in ROCKVILLE, MD. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 1778016.
NBP board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Chun Kwok Alan Au | Director | Mar 18, 2026 |
| Emmett Cunningham | Director | Mar 18, 2026 |
| Martin William Dewhurst | Director | Sep 10, 2026 |
| Wei Fu | Director | Jun 30, 2026 |
| Xi-Yong Fu | See Remarks | Mar 18, 2026 |
| Srishti Gupta | Chief Executive Officer | Jul 8, 2026 |
| Robert A. Lenz | Director | Aug 25, 2026 |
| Xin Liu | Director | Mar 18, 2026 |
| Ian Ying Woo | Director | Mar 18, 2026 |
| Conor Chia-Hung Yang | Director | Apr 1, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Sean Wuxiong Cao | Chief Bus. Development Officer | Sep 11, 2026 |
| Denny Hsueh Wen Chu | See Remarks | Mar 24, 2026 |
| Phillip Andrew Dennis | Chief Medical Officer | Sep 21, 2026 |
| Xi-Yong Fu | See Remarks | Mar 18, 2026 |
| Srishti Gupta | Chief Executive Officer | Jul 8, 2026 |
| Mark Arnold Hagler | Chief Commercial Officer | Jul 10, 2026 |
| Ming Kyler Lei | Chief Financial Officer | Mar 18, 2026 |
| Liwei Lorraine Lin | General Counsel | Jul 10, 2026 |
| Joanna Xuqiong Wu | See Remarks | Mar 18, 2026 |
| Cong Claire Xu | EVP, Clinical Development | Sep 1, 2026 |
| Adeline Yi Zhang | Global Controller | Mar 18, 2026 |
| Xiaofan Neo Zhang | Chief Investment Officer | Mar 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 18, 2026 | Phillip Andrew Dennis | Sale | 8,209 | $0.71 |
| Sep 18, 2026 | Phillip Andrew Dennis | Sale | 8,209 | $0.71 |
| Sep 18, 2026 | Phillip Andrew Dennis | Sale | 8,209 | $0.71 |
| Sep 18, 2026 | Phillip Andrew Dennis | Sale | 8,209 | $0.71 |
| Sep 9, 2026 | Sean Wuxiong Cao | Sale | 107,978 | $0.74 |
| Sep 9, 2026 | Sean Wuxiong Cao | Sale | 107,978 | $0.74 |
| Sep 9, 2026 | Sean Wuxiong Cao | Sale | 107,978 | $0.74 |
| Sep 9, 2026 | Sean Wuxiong Cao | Sale | 107,978 | $0.74 |
| Aug 31, 2026 | Cong Claire Xu | Sale | 3,282 | $0.79 |
| Aug 31, 2026 | Cong Claire Xu | Sale | 3,282 | $0.79 |
| Aug 31, 2026 | Cong Claire Xu | Sale | 3,282 | $0.79 |
| Aug 31, 2026 | Cong Claire Xu | Sale | 3,282 | $0.79 |
| Jul 6, 2026 | Cong Claire Xu | Sale | 4,485 | $0.89 |
| Jul 6, 2026 | Cong Claire Xu | Sale | 4,485 | $0.89 |
| Jul 6, 2026 | Cong Claire Xu | Sale | 4,485 | $0.89 |
NBP financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
NBP earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NBP
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.